Dyskeratosis congenita

Common Name(s)

Dyskeratosis congenita, Zinsser-Cole-Engman syndrome

Dyskeratosis congenita (DKC) is a rare genetic condition that affects many parts of the body. The three major features seen in DKC include abnormally shaped fingernails and toenails that grow poorly (nail dystrophy), changes in skin coloring (pigmentation) on the neck and chest, and white patches inside the mouth (oral leukoplakia). In addition, people with DKC can also have abnormal bone marrow function (bone marrow failure), abnormal blood cell development (myelodysplastic syndrome), an increased risk for blood based cancer (leukemia), lung problems, eye abnormalities, dental problems, prematurely grey hair, hair loss, low bone mineral density (osteoporosis), and liver disease. The severity of symptoms varies and some people with DKC only have a few mild features.

Mutations (changes) within several genes have been associated with DKC. Not all genes are known however, as only 60% of people with DKC have had disease-causing mutations identified. DKC can be inherited in many different ways, depending on which gene is causing the disease. One form of DKC affects males only, while the others affect males and females equally. There is no cure for DKC, but treatment options are available to help with some of the symptoms. If you or someone you know has this diagnosis, talk to your doctor about the most current treatment options. Support groups are a good source of information and can put you in contact with other families.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Dyskeratosis congenita" for support, advocacy or research.

Dyskeratosis Congenita Outreach, Inc.

Our mission is to provide information and support services to families affected by Dyskeratosis Congenita, a Telomere Biology Disorder worldwide, to encourage the medical community's research in finding causes and effective treatments, and to facilitate improved diagnosis by educating medical providers.

Last Updated: 1 Nov 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Dyskeratosis congenita" for support, advocacy or research.

Dyskeratosis Congenita Outreach, Inc.

Our mission is to provide information and support services to families affected by Dyskeratosis Congenita, a Telomere Biology Disorder worldwide, to encourage the medical community's research in finding causes and effective treatments, and to facilitate improved diagnosis by educating medical providers.

http://www.dcoutreach.com

Last Updated: 1 Nov 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Dyskeratosis congenita" returned 123 free, full-text research articles on human participants. First 3 results:

Dyskeratosis Congenita.
 

Author(s): Daniel A Kelmenson, Michael Hanley

Journal: N. Engl. J. Med.. 2017 Apr;376(15):1460.

 

Last Updated: 31 Dec 1969

Go To URL
Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.
 

Author(s): Jin Imai, Takayoshi Suzuki, Marie Yoshikawa, Makiko Dekiden, Hirohiko Nakae, Fumio Nakahara, Shingo Tsuda, Hajime Mizukami, Jun Koike, Muneki Igarashi, Hiromasa Yabe, Tetsuya Mine

Journal: Intern. Med.. ;55(23):3441-3444.

 

Dyskeratosis congenita (DC) is a rare inherited disease in which the telomere complex cannot be maintained. Shortened telomeres can cause a number of clinical conditions. We herein report a case of unrelated bone marrow transplantation due to aplastic anemia associated with DC. The ...

Last Updated: 31 Dec 1969

Go To URL
Diffuse Mesangial Sclerosis in a Child With Dyskeratosis Congenita Leading to End-stage Renal Disease.
 

Author(s): Abidi Kamel, Taha Sayari, Manel Jellouli, Yousra Hammi, Rim Ghoucha Louzir, Tahar Gargah

Journal: Iran J Kidney Dis. 2016 Nov;10(6):416-418.

 

Dyskeratosis congenita (DC) is a very rare inherited disorder. It is caused by dysfunction of telomere maintenance. It involves RNA telomerase components relevant to various mutations leading to a classic triad of physical findings consisting of nail dystrophy of the hands and feet, ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Dyskeratosis congenita" returned 11 free, full-text review articles on human participants. First 3 results:

Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
 

Author(s): Maria M Gramatges, Alison A Bertuch

Journal: Transl Res. 2013 Dec;162(6):353-63.

 

Telomeres are DNA-protein structures that form a protective cap on chromosome ends. As such, they prevent the natural ends of linear chromosomes from being subjected to DNA repair activities that would result in telomere fusion, degradation, or recombination. Both the DNA and protein ...

Last Updated: 31 Dec 1969

Go To URL
[Dyskeratosis congenita: short telomeres are not the rule].
 

Author(s): Fabien Touzot, Tangui Le Guen, Jean-Pierre de Villartay, Patrick Revy

Journal: Med Sci (Paris). ;28(6-7):618-24.

 

Telomeres are nucleoprotein structures at the end of linear chromosomes. Their length, structure, and integrity are regulated by the telomerase complex, the shelterins and components of the DNA damage response. In human subjects, defects in telomere maintenance are responsible for ...

Last Updated: 31 Dec 1969

Go To URL
The genetics of dyskeratosis congenita.
 

Author(s): Philip J Mason, Monica Bessler

Journal: Cancer Genet. 2011 Dec;204(12):635-45.

 

Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome associated with characteristic mucocutaneous features and a variable series of other somatic abnormalities. The disease is heterogeneous at the genetic and clinical levels. Determination of the genetic basis ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
 

Status: Recruiting

Condition Summary: Dyskeratosis Congenita; Aplastic Anemia

 

Last Updated: 3 Dec 2017

Go to URL
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
 

Status: Recruiting

Condition Summary: Dyskeratosis Congenita; Hoyeraal Hreidarsson Syndrome; Revesz Syndrome; Aplastic Anemia

 

Last Updated: 21 Jul 2017

Go to URL
Familial Investigations of Childhood Cancer Predisposition
 

Status: Recruiting

Condition Summary: Acute Leukemia; Adenomatous Polyposis; Adrenocortical Carcinoma; AML; BAP1 Tumor Predisposition Syndrome; Carney Complex; Choroid Plexus Carcinoma; Constitutional Mismatch Repair Deficiency Syndrome; Diamond-Blackfan Anemia; DICER1 Syndrome; Dyskeratosis Congenita; Emberger Syndrome; Familial Acute Myeloid Leukaemia; Familial Adenomatous Polyposis; Fanconi Anemia; Familial Cancer; Familial Wilms Tumor; Familial Neuroblastoma; GIST; Hereditary Breast and Ovarian Cancer; Hereditary Paraganglioma-Pheochromocytoma Syndrome; Hodgkin Lymphoma; Juvenile Polyposis; Li-Fraumeni Syndrome; Lynch Syndrome; MDS; Melanoma Syndrome; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Neuroblastoma; Neurofibromatosis Type 1; Neurofibromatosis Type II; Nevoid Basal Cell Carcinoma Syndrome; Non Hodgkin Lymphoma; Noonan Syndrome and Other Rasopathy; Overgrowth Syndromes; Pancreatic Cancer; Peutz-Jeghers Syndrome; Pheochromocytoma/Paraganglioma; PTEN Hamartoma Tumor Syndrome; Retinoblastoma; Rhabdoid Tumor Predisposition Syndrome; Rhabdomyosarcoma; Rothmund-Thomson Syndrome; Tuberous Sclerosis; Von Hippel-Lindau Disease

 

Last Updated: 27 Oct 2017

Go to URL